ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,561Medicare Part D Prescriptions Filled, Including Refills

Rank: 43 out of 3001

$1.29M Total Retail Price of All Prescriptions

Rank: 57 out of 3001

418 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 418 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 418 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 19,524 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

56 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
LEVOTHYROXINE SODIUM 923 791 1 3
WARFARIN SODIUM 765 663 2 12
SIMVASTATIN 699 585 3 1
OMEPRAZOLE 671 594 4 4
FUROSEMIDE 517 490 5 6
DONEPEZIL HCL 453 444 6 27
METOPROLOL TARTRATE 452 405 7 8
HYDROCODONE-ACETAMINOPHEN 416 335 S3 8 7
NAMENDA 397 381 9 40
LISINOPRIL 396 362 10 2
CITALOPRAM HBR 395 329 11 16
TRAMADOL HCL 359 267 12 17
METFORMIN HCL 356 257 13 9
AMLODIPINE BESYLATE 352 346 14 5
BUMETANIDE 349 308 15 151
POTASSIUM CHLORIDE 331 272 16 15
JANTOVEN 300 299 17 110
POLYETHYLENE GLYCOL 3350 267 223 18 55
DIVALPROEX SODIUM 265 190 19 70
ATENOLOL 263 209 20 18
CLONIDINE HCL 215 183 21 64
GABAPENTIN 209 170 22 14
MIRTAZAPINE 209 192 22 44
QUETIAPINE FUMARATE 209 161 22 66
FENTANYL 200 172 S2 25 76
ISOSORBIDE MONONITRATE ER 197 176 26 45
ATORVASTATIN CALCIUM 193 155 27 11
DIGOXIN 192 190 28 65
OXYCODONE-ACETAMINOPHEN 191 152 S2 29 32
SERTRALINE HCL 182 146 30 20
CARVEDILOL 182 171 30 25
ALBUTEROL SULFATE 182 167 30 99
NOVOLIN R 173 133 33 174
IBUPROFEN 154 126 34 74
HALOPERIDOL 152 82 35 147
IPRATROPIUM BROMIDE 145 130 36 183
KLOR-CON M10 143 143 37 138
CLOZAPINE 137 31 38 170
HYDROCHLOROTHIAZIDE 135 109 39 10
CIPROFLOXACIN HCL 133 111 40 56
LANTUS 131 91 41 47
METOPROLOL SUCCINATE 129 116 42 19
ALLOPURINOL 129 120 42 35
KETOCONAZOLE 126 87 44 185
CLOPIDOGREL 123 106 45 28
OXYBUTYNIN CHLORIDE ER 122 79 46 79
KLOR-CON M20 120 105 47 52
CARBIDOPA-LEVODOPA 116 78 48 97
PHENYTOIN SODIUM EXTENDED 115 82 49 126
CEPHALEXIN 110 96 50 86
ENALAPRIL MALEATE 110 89 50 83
ESCITALOPRAM OXALATE 108 97 52 82
TAMSULOSIN HCL 107 87 53 29
LACTULOSE 105 81 54 116
GLIPIZIDE 105 67 54 67
NITROFURANTOIN MONO-MACRO 105 67 54 158
IPRATROPIUM-ALBUTEROL 104 103 57 119
LYRICA 97 75 58 87
LEVEMIR FLEXPEN 97 83 58 188
NOVOFINE AUTOCOVER 96 86 60 277
TRAZODONE HCL 95 81 61 37
PLAVIX 95 87 61 46
PAROXETINE HCL 94 69 63 60
DIOVAN 93 80 64 50
ALENDRONATE SODIUM 93 87 64 26
CELEBREX 93 80 64 89
PRAVASTATIN SODIUM 91 80 67 13
ROPINIROLE HCL 91 73 67 88
NEXIUM 90 89 69 23
FAMOTIDINE 89 60 70 68
CYMBALTA 87 79 71 53
CYCLOBENZAPRINE HCL 87 61 R 71 73
METOCLOPRAMIDE HCL 87 68 71 139
NITROGLYCERIN PATCH 87 87 71 220
PROMETHAZINE HCL 85 64 R 75 93
RISPERIDONE 83 81 76 63
ADVAIR DISKUS 83 64 76 58
AZITHROMYCIN 82 63 78 36
MELOXICAM 82 69 78 34
HYDRALAZINE HCL 82 79 78 104
GEMFIBROZIL 79 50 81 117
VERAPAMIL ER 78 68 82 102
DILANTIN 77 61 83 225
JANUVIA 76 51 84 54
SEROQUEL 76 66 84 146
GLYBURIDE 76 72 R 84 62
BACLOFEN 74 40 87 125
PHENYTOIN 73 50 88 286
PREDNISONE 73 52 88 39
CARBAMAZEPINE 73 48 88 134
PANTOPRAZOLE SODIUM 72 59 91 43
NOVOLOG FLEXPEN 72 56 91 169
LEVETIRACETAM 72 52 91 112
ZOLPIDEM TARTRATE 72 56 91 24
SODIUM CHLORIDE 71 58 95 199
GLIMEPIRIDE 71 60 95 31
NOVOLOG 70 59 97 94
EXELON 69 59 98 108
OLANZAPINE 68 26 99 106
MUPIROCIN 67 52 100 180
SULFAMETHOXAZOLE-TRIMETHOPRIM 66 61 101 77
ISOSORBIDE DINITRATE 64 54 102 232
LOSARTAN POTASSIUM 64 64 102 21
BENZTROPINE MESYLATE 63 40 R 104 127
LEVEMIR 62 59 105 204
DIVALPROEX SODIUM ER 61 48 106 142
TRAVATAN Z 60 43 107 230
NITROFURANTOIN 60 39 107 240
HYDROXYZINE HCL 58 58 R 109 172
DESOXIMETASONE 58 50 109 375
CLOTRIMAZOLE-BETAMETHASONE 57 43 111 181
VENLAFAXINE HCL 54 41 112 171
TORSEMIDE 53 50 113 161
MIDODRINE HCL 53 39 113 305
LIDODERM 53 40 113 122
CRESTOR 52 44 116 33
DILTIAZEM HCL 52 52 116 245
VESICARE 52 40 116 244
SOTALOL 51 51 119 266
VALPROIC ACID 50 43 120 213
OXYBUTYNIN CHLORIDE 50 39 120 120
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 20, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.